Moore Capital Management, LP Acumen Pharmaceuticals, Inc. Transaction History

Moore Capital Management, LP

  • $7.76 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$4.81 - $10.17 $1.9 Million - $4.02 Million
-395,324 Reduced 93.48%
27,578 $148,000
Q3 2022

Nov 14, 2022
BUY
$4.44 - $10.48 $286,024 - $675,121
64,420 Added 17.97%
422,902 $4.24 Million
Q4 2021

Feb 14, 2022
SELL
$6.54 - $15.31 $72,600 - $169,956
-11,101 Reduced 3.0%
358,482 $2.42 Million
Q3 2021

Nov 15, 2021
BUY
$14.5 - $20.28 $5.36 Million - $7.5 Million
369,583 New
369,583 $5.49 Million

Others Institutions Holding ABOS

# of Institutions
81
Shares Held
40.6M
Call Options Held
28.6K
Put Options Held
76.4K
View Full List

About Acumen Pharmaceuticals, Inc.

ABOS Quotes by TradingView
  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $50.2M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Moore Capital Management, LP Portfolio

Follow Moore Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Moore Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email